Skip to content

The Cognitive Variability in NF1 and TSC Monozygotic Twins

The Cognitive Variability in Neurofibromatosis Type I and Tuberous Sclerosis Complex Monozygotic Twins

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02436746
Acronym
COVANTT
Enrollment
116
Registered
2015-05-07
Start date
2015-04-30
Completion date
2017-04-30
Last updated
2015-05-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurofibromatosis Type I, Tuberous Sclerosis Complex

Keywords

Von Recklinghausen's disease, Bourneville's disease, Cognitive variability, Loss of heterozygosity

Brief summary

Both Neurofibromatosis type 1 (NF1) and Tuberous Sclerosis Complex (TSC) are highly heterogeneous diseases. Cognitive features seem to vary widely even between family members carrying the same mutation. This phenotypic variability is not well understood, but is generally assumed to be caused by modifier genes which regulate the affected pathways. However, recent studies brought forward an alternative explanation for the phenotypic variability. Post-mortem studies showed that second hit mutations causing loss of the second ('healthy') allele are more widespread than previously believed. These loss of heterozygosity (LOH) mutations cause bi-allelic loss of the disease-linked gene and are known to cause the gross of somatic features in both diseases (like neurofibromas and hamartomas). Hence, it could be the stochastic occurrence of second-hit mutations in the brain are the cause of the variable cognitive phenotypes. To investigate to what extent these LOH mutations in the brain contribute to the phenotype and to what extent this variation is due to genetic modifiers factors is unknown. The investigators therefore propose to elucidate this variability by comparing the correlation of cognitive features of monozygotic twins with NF1 or TSC to healthy twins in the population. If modifier genes are the cause of the variability of cognitive features in NF1 and TSC the investigators expect that the variability in cognitive tests in monozygotic twins is the same as monozygotic twins in the healthy population. However, if the variability is caused by the occurrence of LOH mutations, the investigators expect to have a lower correlation in our monozygotic patients compared to the healthy twins.

Interventions

None listed

Sponsors

Erasmus Medical Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* The participant is part of a monozygotic twin pair (which is genetically confirmed); * NF1 or TSC patients with a genetically confirmed diagnosis; * Oral and written informed consent by participant in case ≥ 18 years of age. * Oral and written informed consent by both caregivers and assent by participant in case of minor participants.

Exclusion criteria

* A potential subject of whom the twin sibling is not willing or able to participate in this study, will be excluded from participation in this study. * Symptomatic brain pathology.

Design outcomes

Primary

MeasureTime frameDescription
Correlation of full intelligence quotient1 dayDepending on age and cognitive development: Bayley Scales of Infant Development (BSID-III) or Wechsler Scale of Intelligence (Wechsler Preschool and Primary Scale of Intelligence (WPPSI-III) or Wechsler Intelligence Scale for Children (WISC-III) or Wechsler Adult Intelligence Scale (WAIS-III) )

Secondary

MeasureTime frameDescription
Correlation of attention problems1 dayConners ADHD rating scale
Correlation of behavioural problems1 dayChild Behaviour Checklist or Adult Behaviour Checklist (CBCL/ABCL)
Correlation of word reading ability1 dayOne-minute word-reading test
Correlation of visuospatial judgement (NF1 twins only)1 dayJudgement of Line Orientation (JLO)
Correlation of executive control (TSC twins only)1 dayTrail-Making Test parts A & B (TMT)
Correlation of autistic features1 daySocial Responsiveness Scale (SRS)

Countries

Netherlands

Contacts

Primary ContactYpe Elgersma, Prof.
y.elgersma@erasmusmc.nl+31 10 7037739
Backup ContactAndré Rietman, MSc.
a.rietman@erasmusmc.nl+31 10 7043829

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026